These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31036648)

  • 1. A nanoelectronics-blood-based diagnostic biomarker for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Esfandyarpour R; Kashi A; Nemat-Gorgani M; Wilhelmy J; Davis RW
    Proc Natl Acad Sci U S A; 2019 May; 116(21):10250-10257. PubMed ID: 31036648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study.
    Lidbury BA; Kita B; Lewis DP; Hayward S; Ludlow H; Hedger MP; de Kretser DM
    J Transl Med; 2017 Mar; 15(1):60. PubMed ID: 28302133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-Based Blood Biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Missailidis D; Sanislav O; Allan CY; Annesley SJ; Fisher PR
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing a Blood Cell-Based Diagnostic Test for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Using Peripheral Blood Mononuclear Cells.
    Xu J; Lodge T; Kingdon C; Strong JWL; Maclennan J; Lacerda E; Kujawski S; Zalewski P; Huang WE; Morten KJ
    Adv Sci (Weinh); 2023 Oct; 10(30):e2302146. PubMed ID: 37653608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are Circulating Fibroblast Growth Factor 21 and N-Terminal Prohormone of Brain Natriuretic Peptide Promising Novel Biomarkers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
    Domingo JC; Cordobilla B; Ferrer R; Giralt M; Alegre-Martín J; Castro-Marrero J
    Antioxid Redox Signal; 2021 Jun; 34(18):1420-1427. PubMed ID: 33353469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of Activin B as a Clinical Biomarker in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Gravelsina S; Nora-Krukle Z; Vilmane A; Svirskis S; Vecvagare K; Krumina A; Murovska M
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    de Vega WC; Herrera S; Vernon SD; McGowan PO
    BMC Med Genomics; 2017 Feb; 10(1):11. PubMed ID: 28231836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review.
    Maksoud R; Magawa C; Eaton-Fitch N; Thapaliya K; Marshall-Gradisnik S
    BMC Med; 2023 May; 21(1):189. PubMed ID: 37226227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Long-Term Cryopreservation on Blood Immune Cell Markers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Biomarker Discovery.
    Gómez-Mora E; Carrillo J; Urrea V; Rigau J; Alegre J; Cabrera C; Oltra E; Castro-Marrero J; Blanco J
    Front Immunol; 2020; 11():582330. PubMed ID: 33329554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new approach to find biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) by single-cell Raman micro-spectroscopy.
    Xu J; Potter M; Tomas C; Elson JL; Morten KJ; Poulton J; Wang N; Jin H; Hou Z; Huang WE
    Analyst; 2019 Jan; 144(3):913-920. PubMed ID: 30207334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myalgic Encephalomyelitis (ME), Chronic Fatigue Syndrome (CFS), and Chronic Fatigue (CF) are distinguished accurately: results of supervised learning techniques applied on clinical and inflammatory data.
    Maes M; Twisk FN; Johnson C
    Psychiatry Res; 2012 Dec; 200(2-3):754-60. PubMed ID: 22521895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics and cytokine analyses distinguish myalgic encephalomyelitis/chronic fatigue syndrome cases from controls.
    Giloteaux L; Li J; Hornig M; Lipkin WI; Ruppert D; Hanson MR
    J Transl Med; 2023 May; 21(1):322. PubMed ID: 37179299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in DNA methylation profiles of myalgic encephalomyelitis/chronic fatigue syndrome patients reflect systemic dysfunctions.
    Helliwell AM; Sweetman EC; Stockwell PA; Edgar CD; Chatterjee A; Tate WP
    Clin Epigenetics; 2020 Nov; 12(1):167. PubMed ID: 33148325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunometabolic changes and potential biomarkers in CFS peripheral immune cells revealed by single-cell RNA sequencing.
    Sun Y; Zhang Z; Qiao Q; Zou Y; Wang L; Wang T; Lou B; Li G; Xu M; Wang Y; Zhang Z; Hou X; Chen L; Zhao R
    J Transl Med; 2024 Oct; 22(1):925. PubMed ID: 39394558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in chronic fatigue syndrome/myalgic encephalomyelitis patients.
    Nguyen T; Johnston S; Chacko A; Gibson D; Cepon J; Smith P; Staines D; Marshall-Gradisnik S
    Asian Pac J Allergy Immunol; 2017 Jun; 35(2):75-81. PubMed ID: 27362406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating levels of GDF15 in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Melvin A; Lacerda E; Dockrell HM; O'Rahilly S; Nacul L
    J Transl Med; 2019 Dec; 17(1):409. PubMed ID: 31801546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome.
    Landi A; Broadhurst D; Vernon SD; Tyrrell DL; Houghton M
    Cytokine; 2016 Feb; 78():27-36. PubMed ID: 26615570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome.
    Gravelsina S; Vilmane A; Svirskis S; Rasa-Dzelzkaleja S; Nora-Krukle Z; Vecvagare K; Krumina A; Leineman I; Shoenfeld Y; Murovska M
    Front Immunol; 2022; 13():928945. PubMed ID: 36300129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomic Evidence for Peroxisomal Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Che X; Brydges CR; Yu Y; Price A; Joshi S; Roy A; Lee B; Barupal DK; Cheng A; Palmer DM; Levine S; Peterson DL; Vernon SD; Bateman L; Hornig M; Montoya JG; Komaroff AL; Fiehn O; Lipkin WI
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Maes M; Kubera M; Uytterhoeven M; Vrydags N; Bosmans E
    Med Sci Monit; 2011 Apr; 17(4):SC11-5. PubMed ID: 21455120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.